|
SEPT7P2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-16 |
| Normal-vs-Stage2 |
1.71409999971672E-07 |
| Normal-vs-Stage3 |
8.88178419700125E-16 |
| Normal-vs-Stage4 |
1.2319000264327E-09 |
| Stage1-vs-Stage2 |
5.271600E-01 |
| Stage1-vs-Stage3 |
2.602000E-02 |
| Stage1-vs-Stage4 |
3.626800E-01 |
| Stage2-vs-Stage3 |
5.329800E-02 |
| Stage2-vs-Stage4 |
2.610400E-01 |
| Stage3-vs-Stage4 |
6.189000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.28900000462684E-08 |
| Normal-vs-Asian |
1.58790000004405E-06 |
| Caucasian-vs-AfricanAmerican |
7.544800E-01 |
| Caucasian-vs-Asian |
4.013500E-02 |
| AfricanAmerican-vs-Asian |
1.111000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27009958106328E-10 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.964000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
2.14273043752655E-14 |
| Normal-vs-Age(61-80Yrs) |
4.1115999493968E-10 |
| Normal-vs-Age(81-100Yrs) |
1.86263999999436E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.625000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.605600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.840800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.566400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.852600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.642800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.73659999997056E-06 |
| Classical-VS-Follicular |
5.399800E-02 |
| Classical-VS-Other |
9.394200E-01 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
3.47529999999985E-07 |
| Tall-VS-Other |
2.141500E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.811200E-01 |
| Follicular-VS-Normal |
6.14369999984987E-07 |
| Other-VS-Normal |
1.940760E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.30735439035834E-13 |
| Normal-vs-N1 |
3.57480000046095E-07 |
| N0-vs-N1 |
9.736600E-01 |
|
|
